Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022
March 03 2022 - 8:03AM
Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop
synthetic biology systems, today announced details for its first
Investor R&D Webinar. Management will describe the future
promise of the company’s R&D pipeline, with a specific focus on
its proprietary Short Oligo Ligation Assembly (SOLA) enzymatic DNA
synthesis technology.
The webinar will be held virtually on March 29, 2022,
beginning at 8:00 a.m. Pacific time / 11:00 a.m. Eastern time.
The event should conclude at approximately 9:00 a.m. Pacific
Time / 12:00 p.m. Eastern time.
Attendees are encouraged to pre-register for the webcast by
following this link and completing the registration form.
A link to the live webcast and related materials will also be
available in the Investor Relations section of Codex DNA’s website,
https://ir.codexdna.com. An archived replay of each webcast will be
available following the event.
About Codex DNACodex DNA is
empowering scientists with the ability to create novel, synthetic
biology-enabled solutions for many of humanity’s greatest
challenges. As inventors of the industry-standard Gibson Assembly®
method and the first commercial automated benchtop DNA and mRNA
synthesis system, Codex DNA is enabling rapid, accurate, and
reproducible writing of DNA and mRNA for numerous downstream
markets. The company’s award-winning BioXp™ system consolidates,
automates, and optimizes the entire synthesis, cloning, and
amplification workflow. As a result, it delivers virtually
error-free synthesis of DNA/RNA at scale within days and hours
instead of weeks or months. Scientists around the world are using
the technology in their own laboratories to accelerate the
design-build-test paradigm for novel, high-value products for
precision medicine, biologics drug discovery, vaccine and
therapeutic development, genome editing, and cell and gene therapy.
Codex DNA is a public company based in San Diego. For more
information, visit codexdna.com.
Contact:Richard LepkeDirector of Investor
Relations(619) 840-5392RichardL@codexdna.com
Codex DNA (NASDAQ:DNAY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Codex DNA (NASDAQ:DNAY)
Historical Stock Chart
From Jul 2023 to Jul 2024